Completed PHASE4 INTERVENTIONAL 3-arm NCT05293808

Platelet Aggregation in Diabetic Patients With Acute Coronary Syndrome Treated With Different Doses of Aspirin (DIABE-ASACS)

Evaluation of Different Doses of Aspirin on Platelet Aggregation in Diabetic Patients With Acute Coronary Syndrome

Sponsor: Federico II University

Conditions Acute Coronary Syndrome Diabetes Mellitus

Interventions aspirin 100 mg bis in die aspirin 100 mg once daily aspririn 200 mg once daily

Updated 4 times since 2022 Last updated: Feb 22, 2024 Started: May 1, 2014 Primary completion: Oct 1, 2014 Completion: Jan 1, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT05293808, this PHASE4 trial focuses on Acute Coronary Syndrome and Diabetes Mellitus and remains completed. Sponsored by Federico II University, it has been updated 4 times since 2014, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Mar 2024 — Jul 2024 [monthly]

Completed PHASE4
Apr 2022 — Mar 2024 [monthly]

Completed PHASE4

First recorded

May 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Federico II University

Data source: Federico II University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Naples, Italy